Literature DB >> 2773995

Chromosome mosaicism in 6,000 amniocenteses.

M G Wilson1, M S Lin, A Fujimoto, W Herbert, F M Kaplan.   

Abstract

Multiple cell-multiple flask mosaicism was found in 0.20% of 6,000 amniocenteses, and multiple cell-single flask mosaicism was found in 0.92%. Multiple cell-multiple flask mosaicism usually was found in fetal or infant tissues at delivery or elective abortion. Most multiple cell-multiple flask mosaicism involved sex chromosomes and was either 45, X/46, XY or 45, X/46, XX. Except for one fetus with 45, X/46, XX and an aortic coarctation, phenotypic abnormalities associated with sex chromosome mosaicism were not found in these patients. One normal boy has continued to show 45,X mosaicism during the first 4 years of life. Autosome abnormalities found in multiple cell-multiple flask mosaicism included del(18q) associated with fetal anomalies. Apparently normal phenotypes were associated with prenatal trisomy 17, two de novo supernumerary marker chromosomes, and monosomy 21. Since an aberrant cell line present in only one primary amniotic fluid cell culture was occasionally identified from another amniocentesis or at birth, multiple cell-single flask mosaicism involving a sex chromosome or a viable autosome abnormality cannot be assumed to be an in vitro event. Maternal cell contamination, which was found in 0.49% of amniocenteses, could have resulted in an erroneous diagnosis of fetal sex in two cases if cells from independent culture vessels were not examined.

Entities:  

Mesh:

Year:  1989        PMID: 2773995     DOI: 10.1002/ajmg.1320320417

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Early assessment of ambiguous genitalia.

Authors:  A L Ogilvy-Stuart; C E Brain
Journal:  Arch Dis Child       Date:  2004-05       Impact factor: 3.791

Review 2.  New issues in the diagnosis and management of Turner syndrome.

Authors:  Carolyn A Bondy
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

3.  A clinical and molecular study of mosaicism for trisomy 17.

Authors:  L G Shaffer; C McCaskill; J H Hersh; F Greenberg; J R Lupski
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

4.  A molecular, cytogenetic, and clinical evaluation of mosaic tandem duplication 17p and Charcot-Marie-Tooth type 1A neuropathy.

Authors:  K S Reddy; M B Larsen
Journal:  J Med Genet       Date:  1998-02       Impact factor: 6.318

5.  Mosaic trisomy 17: variable clinical and cytogenetic presentation.

Authors:  Robert Daber; Kimberly A Chapman; Eduardo Ruchelli; Stefanie Kasperski; Surabhi Mulchandani; Brian D Thiel; Hakon Hakonarson; Elaine H Zackai; Laura K Conlin; Nancy B Spinner
Journal:  Am J Med Genet A       Date:  2011-10       Impact factor: 2.802

6.  Prenatal diagnosis of 45,X/46,XX mosaicism and 45,X: implications for postnatal outcome.

Authors:  D D Koeberl; B McGillivray; V P Sybert
Journal:  Am J Hum Genet       Date:  1995-09       Impact factor: 11.025

7.  Prenatally Diagnosed Rare Trisomy 16 Mosaicism in Human Amniotic Fluid Cells in the Second Trimester: A Case Report.

Authors:  Sook Ryung Kim; Eun Jung Choi; Young Joo Kim; Tae Yoon Kim; Young Jin Lee
Journal:  Dev Reprod       Date:  2018-06-30

8.  The accuracy of chromosomal microarray testing for identification of embryonic mosaicism in human blastocysts.

Authors:  Veronica Novik; Emily B Moulton; Michael E Sisson; Shagun L Shrestha; Khoa D Tran; Harvey J Stern; Brian D Mariani; Wayne S Stanley
Journal:  Mol Cytogenet       Date:  2014-02-28       Impact factor: 2.009

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.